| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000023401 |
| Receipt No. | R000026960 |
| Official scientific title of the study | Investigation of the effects of sweet potato stem/leaf extract - containing soft capsule on cognitive functions in a healthy population: a double-blind, randomized placebo-controlled and parallel study |
| Date of disclosure of the study information | 2018/04/29 |
| Last modified on | 2019/03/05 (Ver. 5) |
| Basic information | ||
| Official scientific title of the study | Investigation of the effects of sweet potato stem/leaf extract - containing soft capsule on cognitive functions in a healthy population: a double-blind, randomized placebo-controlled and parallel study | |
| Title of the study (Brief title) | Investigation of the effects of sweet potato stem/leaf extract - containing soft capsule on cognitive functions | |
| Region |
|
|
| Condition | |||
| Condition | Healthy volunteers | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | To investigate the effect of the test food to improve cognition in healthy adults |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Cognitrax
Alzheimer's Disesase Assessment Scale-cognitive component -Japanese version |
| Key secondary outcomes | Safety evaluation,
Oxidative stress markers in Blood, Brain-derived neurotrophic factor in Blood |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Double blind -all involved are blinded |
| Control | Placebo |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 3 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | Intake of Test food (6 weeks) | |
| Interventions/Control_2 | Intake of Test food (6 weeks) | |
| Interventions/Control_3 | Intake of Placebo (6 weeks) | |
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1) Subjects aged from 50 to 79 years old
2) Diagnosis by the principal investigator: mild cognitive impairment 3) Subjects should have an adequate understanding of the objectives and details of this study and the ability to give written informed consent for participation in the study by themselves |
|||
| Key exclusion criteria | 1) Individuals who take anti-dementia drugs
2) Individuals who take health foods relating cognitive function 3) Individuals judged as dementia for the results of HDS-R by the investigator 4) Individuals judged as depression for the results of GDS-S-J by the investigator 5) Individuals having difficulty in color vision 6) Individuals having difficulty in handling for a injury or operation etc. 7) Individuals who took part in another clinical study (intake of a supplemental food or medicine or composition applied to the skin) within 1 month prior to the start of the present study or who are currently taking part in another clinical study or who are willing to take part in another clinical study. 8) Individuals judged inappropriate for the study by the principal investigator |
|||
| Target sample size | 30 | |||
| Research contact person | |
| Name of lead principal investigator | Takashi Asada |
| Organization | Memory clinic Ochanomizu |
| Division name | Memory clinic Ochanomizu |
| Address | 1-5-34 Yushima, Bunkyou-ku, Tokyo |
| TEL | 03-6801-8718 |
| asada@memory-cl.jp | |
| Public contact | |
| Name of contact person | Hitomi Saito |
| Organization | FUJIFILM Corporation |
| Division name | Pharmaceutical & Healthcare Research Laboratories |
| Address | 2-5-1, Suwa, Tama-shi, Tokyo |
| TEL | 080-2119-4836 |
| Homepage URL | |
| Hitomi.saito@fujifilm.com | |
| Sponsor | |
| Institute | Memory clinic Ochanomizu |
| Institute | |
| Department | |
| Funding Source | |
| Organization | FUJIFILM Corporation |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | No significant results could be obtained in this trial with the number of participant. |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000026960 |